Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-072695
Filing Date
2025-07-31
Accepted
2025-07-31 16:10:52
Documents
1
Period of Report
2025-07-29

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2522138-6_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2522138-6_4seq1.xml 4 6900
  Complete submission text file 0001104659-25-072695.txt   8490
Mailing Address 16640 CHESTERFIELD GROVE ROAD SUITE 200 CHESTERFIELD MO 63005
Business Address BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK BALLYCOOLIN DUBLIN L2 15 636-449-1830
AVADEL PHARMACEUTICALS PLC (Issuer) CIK: 0001012477 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O FORTY SEVEN, INC. 1490 O'BRIEN DRIVE, SUITE A MENLO PARK CA 94025
Business Address
McCamish Mark Anthony (Reporting) CIK: 0001390798 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37977 | Film No.: 251171783